Skip to headlines
clockwire Search
LIVE
Ministry says diplomatic recruitment to set record Body of Melbourne Cup race horse found in dumpster New ride-hailing taxi rules take effect tomorrow E.Sun Financial expecting record earnings this year The South Korea discount demands the kitchen sink Germany joyfully thrash Netherlands Gu Lin, Sun and Lyle Lin to remain with Fighters Taiwan finish U-23 Baseball World Cup in fourth place UEFA backs France’s Diallo for FIFA chair Marlon Brando cool to Jensen Huang joke: how the black leather jacket became a meme Russian warplanes enter Taiwan ADIZ CDC raises travel health alert for US on measles spread US asks ICAO to counter flight tactics Operational needs EDITORIAL: Huang’s exit and Taiwan’s AI future

Drugs & pharma · US

Drugs & pharma · US · 12 stories in 48h · Clear all filters

SectorsNovartis 1Novo Nordisk 1
  1. Novo Nordisk expands Novocare program for Wegovy users Markets · DenmarkInvesting.comGB Novo Nordisk expands Novocare program for Wegovy users
  2. Nexentis orders molecules for testing in drug discovery program Markets · USInvesting.comGB Nexentis orders molecules for testing in drug discovery program
  3. The Mirror Drugs & pharma · USThe MirrorGB Pharmacist 'cautions' Ozempic and Wegovy users if taking warfarin
  4. Kodiak Sciences at UBS Global Biopharma Conference 2026: two-drug push Markets · USInvesting.comGB Kodiak Sciences at UBS Global Biopharma Conference 2026: two-drug push
  5. Ynetnews Health · USYnetnewsIL Weight-loss drug Wegovy shows promising results in children as young as 6, major study finds
  6. Yahoo Finance Drugs & pharmaYahoo FinanceUS Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again
  7. Six-year-olds: Novo’s new frontier for weight-loss drugs Markets · USFinancial TimesGB Source has a paywall Six-year-olds: Novo’s new frontier for weight-loss drugsWegovy helped almost 8 in 10 children as young as 6 lose more than 10% of their BMI…
  8. CNBC MarketsCNBCUS Novo says Wegovy injection lowers BMI and obesity rates in children in trialWegovy is already approved to treat obesity in children ages 12 and older, but there are currently no…
  9. Yahoo Finance MarketsYahoo FinanceUS Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine
  10. Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setback Indices · ChinaSouth China Morning PostCN Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setbackShares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US…
  11. Exelixis at UBS conference: zanzalintinib sets up next growth phase Markets · USInvesting.comGB Exelixis at UBS conference: zanzalintinib sets up next growth phase
  12. Novartis wins FDA approval for Cosentyx in polymyalgia rheumatica Markets · SwitzerlandInvesting.comGB Novartis wins FDA approval for Cosentyx in polymyalgia rheumatica

1 more story in other languages (Portuguese 1) ·